feed,title,long_url,short_url
Benzinga,Ideaya Biosciences' IDE397 Shows Preliminary Tolerability In Early-Stage Solid Tumor Trial,https://benzinga.com/general/biotech/22/03/26142174/ideaya-biosciences-ide397-shows-preliminary-tolerability-in-early-stage-solid-tumor-trial,https://bit.ly/3tbi7Yy
Benzinga,This Crypto Mining Company Reports Giving Back To The Communities It Operates In,https://benzinga.com/markets/cryptocurrency/22/03/26137014/this-crypto-mining-company-reports-giving-back-to-the-communities-it-operates-in,https://bit.ly/3w64fRp
